These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14904077)

  • 21. Clotting of fibrinogen. 2. Calorimetry of the reversal of the effect of calcium on clotting with thrombin and with ancrod.
    Mihalyi E; Donovan JW
    Biochemistry; 1985 Jul; 24(14):3443-8. PubMed ID: 3929831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clotting of fibrinogen with aqueous fibrin extract.
    KOPPER PH
    Nature; 1962 Oct; 196():280. PubMed ID: 14034712
    [No Abstract]   [Full Text] [Related]  

  • 23. Transformation of fibrinogen into fibrin. III. Kinetics of the pH change associated with the clotting of fibrinogen.
    MIHALYI E; BILLICK IH
    Biochim Biophys Acta; 1963 Apr; 71():97-108. PubMed ID: 13935712
    [No Abstract]   [Full Text] [Related]  

  • 24. On the nature of forces operating in blood clotting; the clotting of fibrinogen as a two-step reaction.
    MOMMAERTS WF
    J Gen Physiol; 1945 Nov; 29():113-22. PubMed ID: 21005104
    [No Abstract]   [Full Text] [Related]  

  • 25. Simulating fibrin clotting time.
    Marx G
    Med Biol Eng Comput; 2006 Mar; 44(1-2):79-85. PubMed ID: 16929924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the thrombin clotting time. II. The influence of fibrin degradation products.
    Arnesen H
    Scand J Haematol; 1973; 10(4):291-7. PubMed ID: 4764611
    [No Abstract]   [Full Text] [Related]  

  • 27. Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure.
    Henderson SJ; Xia J; Wu H; Stafford AR; Leslie BA; Fredenburgh JC; Weitz DA; Weitz JI
    Thromb Haemost; 2016 Mar; 115(3):533-42. PubMed ID: 26489782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of fibrin formation in exercise-induced activation of coagulation.
    Vogt A; Hofmann V; Straub PW
    Am J Physiol; 1979 Apr; 236(4):H577-9. PubMed ID: 434223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrin assembly after fibrinopeptide A release in model systems and human plasma studied with magnetic birefringence.
    Torbet J
    Biochem J; 1987 Jun; 244(3):633-7. PubMed ID: 3446182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinogen clottability and fibrin formation.
    Alexander B
    Thromb Diath Haemorrh Suppl; 1966; 20():191-200. PubMed ID: 4226518
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrin assembly in human plasma and fibrinogen/albumin mixtures.
    Torbet J
    Biochemistry; 1986 Sep; 25(18):5309-14. PubMed ID: 3768349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms involved in fibrin formation.
    BOYLES PW; FERGUSON JH; MUEHLKE PH
    J Gen Physiol; 1951 May; 34(5):493-513. PubMed ID: 14832433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycolaldehyde induces fibrinogen post-translational modification, delay in clotting and resistance to enzymatic digestion.
    Andrades ME; Lorenzi R; Berger M; Guimarães JA; Moreira JC; Dal-Pizzol F
    Chem Biol Interact; 2009 Aug; 180(3):478-84. PubMed ID: 19397901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.
    He S; Johnsson H; Zabczyk M; Hultenby K; Wallén H; Blombäck M
    Thromb Haemost; 2014 Mar; 111(3):417-28. PubMed ID: 24196490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on blood coagulation. I. Factors involved in the conversion of prothrombin into thrombin and of fibrinogen into fibrin].
    LONG LA; COLPRON G
    Union Med Can; 1961 Jan; 90():22-9. PubMed ID: 13763333
    [No Abstract]   [Full Text] [Related]  

  • 36. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
    Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quantitative determination of protector activity of fibrinogen tryptic hydrolysates].
    Musialkivs'ka AO; Pozdniakova TM; Platonova TM; Khomenko VM
    Ukr Biokhim Zh; 1977; 49(4):118-23. PubMed ID: 19861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The conversion of fibrinogen to fibrin. V. Influence of ionic strength and thrombin concentration on the effectiveness of certain reversible inhibitors.
    SHULMAN S; HERWIG WC; FERRY JD
    Arch Biochem Biophys; 1951 Jul; 32(2):354-8. PubMed ID: 14857755
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fibrinogen and fibrin in the process of blood clotting and fibrinolysis].
    Kowrygo W
    Wiad Lek; 1978 Jun; 31(12):845-48. PubMed ID: 358611
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis.
    He S; Bark N; Wang H; Svensson J; Blombäck M
    J Cardiovasc Pharmacol; 2009 Jan; 53(1):24-9. PubMed ID: 19129740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.